Three MENA Based Startups We Backed That Are Rebuilding Relationships, Travel, and Drug Discovery
The MENA startup ecosystem is entering a new phase.
For years, much of the region's innovation focused on digitizing existing services. Today, we're seeing founders tackle something much bigger: building the infrastructure layers that entire industries will run on.
The most exciting companies aren't simply creating new apps.
They're creating new systems.
This week, we backed three companies operating in completely different markets—relationships, travel, and biotechnology—but all pursuing the same mission: using technology to solve problems that have historically been difficult, expensive, or inefficient to address.
Human Relationships Remain One of the Largest Untapped Infrastructure Markets
Most dating platforms are optimized for engagement.
MAXION is optimized for outcomes.
The company believes the future of relationship technology isn't endless swiping—it's creating infrastructure that helps people build meaningful connections throughout every stage of life.
Their model starts with singles but expands into couples, communities, and long-term relationship support.
What stood out to us was the combination of traction and insight.
MAXION's offline matchmaking operation has already achieved a 96% success rate, generated 350+ media mentions, built a community of 5,200+ approved members, and attracted 32,000+ waitlist applications before large-scale rollout. The company is also one of the few dating platforms operating under the ADGM regulatory framework in the UAE.
Instead of building another dating app, MAXION is building infrastructure for human connection.
That's a much bigger opportunity.
Travel Is Ready for an AI-Native Operating Layer
Travel remains one of the world's most fragmented digital experiences.
A single trip can involve airlines, hotels, tourism boards, transportation providers, activities, payment systems, and customer support teams—all operating independently.
Traveln.ai is building the orchestration layer that connects them.
Its platform uses agentic AI to create personalized, fully bookable travel journeys while allowing airlines, tourism authorities, and travel platforms to maintain control over policies, partnerships, and customer experiences.
What makes the company particularly compelling is the speed of commercial adoption.
Traveln.ai has already secured 8 signed commercial agreements, built a pipeline of 24+ active opportunities, established partnerships across airlines, tourism authorities, travel platforms, and technology providers, and is pursuing an opportunity within a $100B AI-ready travel market.
As AI becomes embedded into every consumer journey, travel is one of the largest industries still waiting for a unified intelligence layer.
Traveln.ai is positioning itself to become that layer.
Drug Discovery Needs Better Reasoning, Not Just Bigger Models
Artificial intelligence has transformed many industries.
Drug discovery remains one of the hardest.
The pharmaceutical industry spends billions every year on high-throughput screening campaigns, testing massive numbers of compounds in search of viable drug candidates.
COGENT3 believes there's a better way.
Rather than relying on larger datasets and larger models, the company has developed an emergent AI architecture designed to identify promising molecular candidates using far less data and significantly lower screening costs.
The market need is enormous.
The pharmaceutical industry spends more than $12 billion annually on screening campaigns, and COGENT3 is already in active conversations with organizations including Amgen, Gilead, Vertex, Dr. Reddy's, and Genentech, while targeting $100K–$300K paid pilot engagements.
If successful, the technology could dramatically reduce the cost and time required to identify promising drug candidates.
That's the type of leverage we look for.
What Connects These Companies
At first glance, dating, travel, and biotechnology have very little in common.
But the founders behind MAXION, Traveln.ai, and COGENT3 are solving the same underlying problem:
Complex systems create friction.
Whether it's finding meaningful relationships, planning global travel, or discovering life-saving medicines, existing solutions often rely on fragmented workflows, disconnected data, and outdated processes.
These founders are rebuilding those systems from the ground up.
That's why we're excited to support them.
The next generation of category-defining companies won't simply improve existing experiences.
They'll become the infrastructure those experiences run on.
We're proud to back MAXION, Traveln.ai, and COGENT3 as they continue scaling from the MENA region to global markets. 🚀
